- Home
- FGI vs APVO Comparison
FGI vs APVO Comparison
Compare FGI & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- APVO
- Stock Information
- Founded
- FGI 1987
- APVO 2016
- Country
- FGI United States
- APVO United States
- Employees
- FGI N/A
- APVO N/A
- Industry
- FGI Industrial Specialties
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- APVO Health Care
- Exchange
- FGI Nasdaq
- APVO Nasdaq
- Market Cap
- FGI 7.9M
- APVO 4.9M
- IPO Year
- FGI 2022
- APVO N/A
- Fundamental
- Price
- FGI $9.50
- APVO $1.50
- Analyst Decision
- FGI
- APVO Strong Buy
- Analyst Count
- FGI 0
- APVO 1
- Target Price
- FGI N/A
- APVO $5,920.00
- AVG Volume (30 Days)
- FGI 2.1M
- APVO 5.8M
- Earning Date
- FGI 11-10-2025
- APVO 11-06-2025
- Dividend Yield
- FGI N/A
- APVO N/A
- EPS Growth
- FGI N/A
- APVO N/A
- EPS
- FGI N/A
- APVO N/A
- Revenue
- FGI $135,904,413.00
- APVO N/A
- Revenue This Year
- FGI $5.57
- APVO N/A
- Revenue Next Year
- FGI $8.02
- APVO N/A
- P/E Ratio
- FGI N/A
- APVO N/A
- Revenue Growth
- FGI 12.30
- APVO N/A
- 52 Week Low
- FGI $2.28
- APVO $1.40
- 52 Week High
- FGI $12.62
- APVO $381.10
- Technical
- Relative Strength Index (RSI)
- FGI 69.59
- APVO 30.51
- Support Level
- FGI N/A
- APVO $1.40
- Resistance Level
- FGI $4.03
- APVO $1.54
- Average True Range (ATR)
- FGI 0.53
- APVO 0.20
- MACD
- FGI 0.19
- APVO 0.03
- Stochastic Oscillator
- FGI 75.28
- APVO 7.63
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.